Since joining the firm 32 years ago, Henry J. Renk has been engaged in all aspects of patent practice, including patent prosecution, counseling and patent infringement litigation. For the last 28 years, he has specialized in complex patent infringement litigation, principally in the pharmaceutical and chemical fields, in various district courts and before the International Trade Commission, including appeals to the United States Court of Appeals for the Federal Circuit. Mr. Renk has appeared as lead trial counsel for AstraZeneca, Bausch & Lomb, Merck, Alcatel, S.C. Johnson, Warner-Lambert Company and Monsanto Company in district court patent litigation, and for Union Carbide Corporation in a state court trade secret case. Mr. Renk also has been trial counsel in patent litigation for those and other clients, including Pharmacia, Novartis, Takeda Chemical Industries, SmithKlineBeecham, The NutraSweet Company, DuPont, IBM and Hoechst Celanese.
He was formerly an adjunct Professor of Law at Pace University School of Law in White Plains, New York, where he taught Patent Law. Awards and Recognition
Mr. Renk was selected as a top intellectual property law practitioner in every edition since 2003 of the Best Lawyers in America. He was also listed as a Top New York City Intellectual Property Litigator in the 2006-2011 issues of Super Lawyers: New York Metro Edition. Mr. Renk was listed in IAM Life Sciences 250- The World's Leading Life Sciences Patent Litigator 2010. He is listed as a leading lawyer in Legal 500 2010 for patent litigation: life sciences/chemical. Mr. Renk was also recognized in IAM 250: The World’s Leading Patent Litigators 2011.